There was a modest, transitory increase in blood pressure after use
They are interested in sustainable results, and they have the clinical experience to know the difference between a dose that is therapeutic and one that is just high
Choose Tirzepatide if: Your primary goal is significant total body weight loss You have elevated glucose readings, prediabetes, and/or metabolic syndrome You struggle with appetite control and food volume Youre willing to tolerate GI side effects during dose titrations You want a compound with robust general population clinical data Choose Tesamorelin if: Your primary goal is visceral fat reduction without systemic appetite suppression You carry excess abdominal fat despite having a somewhat reasonable total body weight You want to preserve and/or enhance lean mass while reducing VAT You want to avoid GLP-1-related GI side effects You understand youre using it off-label if you dont have HIV-associated lipodystrophy Do NOT choose either if: You have a history of pancreatitis (Tirzepatide) You have active cancer (Tesamorelin) Youre pregnant or breastfeeding (both) Youre looking for a shortcut instead of addressing foundational metabolic health (both) These peptides are tools with specific mechanisms suited to specific applications
However, earlier studies showed inconsistences of GIP as a cause of weight loss, although more recent studies have demonstrated increased weight loss efficacy [280,281,282,283]
Research published in Cell Metabolism demonstrated that NAD+ repletion through niacin supplementation improved muscle strength, performance, and mitochondrial biogenesis in human subjects
